公司资料
Coya Therapeutics 股价、新闻与催化剂
- 股票代码:
- COYA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
4.96 USD (+1.85%)
收盘价
最后更新: 2026年8月24日
111M USD
市值
股价为何变动
As of Aug 24, 2026, COYA closed up 1.85% at $4.96. No new same-company headline was identified in the current news window.
公司概览
业务概览
Coya Therapeutics is a biotechnology company focused on immunomodulation and neurodegenerative disease, especially ALS and related conditions. Its story centers on modulating immune pathways to potentially slow neurodegeneration.
所在地与行业分类
Coya is headquartered in the United States and listed on NASDAQ. It sits in neuroscience and immunology biotechnology.
商业模式特征
The company depends on clinical data, translational validation, and capital support while developing a narrow pipeline. Investors watch early efficacy signals and whether the biology can support a differentiated CNS thesis.
生物医药行业定位
Coya occupies a specialized immunology-neuroscience niche within biotech. The stock is catalyst-sensitive because it is still proving whether the platform can matter in neurodegeneration.
未来催化剂
- Coya’s catalysts are its immunomodulation and neuroinflammation programs, where the next clinical update can change how investors view the company. The company remains early and data-dependent.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。